218 related articles for article (PubMed ID: 37647867)
21. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6.
Wu S; Han M; Zhang C
Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027
[TBL] [Abstract][Full Text] [Related]
22. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Wu X; Zhu M; Fletcher JA; Giobbie-Hurder A; Hodi FS
PLoS One; 2012; 7(1):e29622. PubMed ID: 22253748
[TBL] [Abstract][Full Text] [Related]
23. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
24. Elevated ZNF704 expression is associated with poor prognosis of uveal melanoma and promotes cancer cell growth by regulating AKT/mTOR signaling.
Luo J; Li H; Xiu J; Zeng J; Feng Z; Zhao H; Li Y; Wei W
Biomark Res; 2023 Apr; 11(1):38. PubMed ID: 37038184
[TBL] [Abstract][Full Text] [Related]
25. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
Benhassine M; Le-Bel G; Guérin SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
27. Monensin synergizes with chemotherapy in uveal melanoma through suppressing RhoA.
Zeng C; Long M; Lu Y
Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):35-42. PubMed ID: 36043455
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.
Zhang J; Liu S; Ye Q; Pan J
Mol Cancer; 2019 Sep; 18(1):140. PubMed ID: 31526394
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of thrombospondin 2 inhibits metastasis through modulation of PI3K signaling pathway in uveal melanoma cell line M23.
Liu QH; Ma LS
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6230-6238. PubMed ID: 30338785
[TBL] [Abstract][Full Text] [Related]
30. PARP-1 promotes autophagy via the AMPK/mTOR pathway in CNE-2 human nasopharyngeal carcinoma cells following ionizing radiation, while inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells.
Chen ZT; Zhao W; Qu S; Li L; Lu XD; Su F; Liang ZG; Guo SY; Zhu XD
Mol Med Rep; 2015 Aug; 12(2):1868-76. PubMed ID: 25872765
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.
Calipel A; Landreville S; De La Fouchardière A; Mascarelli F; Rivoire M; Penel N; Mouriaux F
Clin Exp Metastasis; 2014 Jun; 31(5):553-64. PubMed ID: 24652072
[TBL] [Abstract][Full Text] [Related]
32. Compound 13, an α1-selective small molecule activator of AMPK, potently inhibits melanoma cell proliferation.
Hu X; Jiang F; Bao Q; Qian H; Fang Q; Shao Z
Tumour Biol; 2016 Jan; 37(1):1071-8. PubMed ID: 26271666
[TBL] [Abstract][Full Text] [Related]
33. Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.
Duan F; Lin M; Li C; Ding X; Qian G; Zhang H; Ge S; Fan X; Li J
Cancer Biol Ther; 2014 May; 15(5):544-59. PubMed ID: 24553082
[TBL] [Abstract][Full Text] [Related]
34. Impact of Nintedanib and Anti-Angiogenic Agents on Uveal Melanoma Cell Behavior.
Pawlik VE; Sonntag SR; Grisanti S; Tura A; Kakkassery V; Ranjbar M
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):30. PubMed ID: 38381412
[TBL] [Abstract][Full Text] [Related]
35. Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.
Refaian N; Schlereth SL; Koch KR; Notara M; Hos D; Mescher M; Iden S; Bosch JJ; Jager MJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5691-7. PubMed ID: 26313304
[TBL] [Abstract][Full Text] [Related]
36. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
[TBL] [Abstract][Full Text] [Related]
37. Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma.
Jin Y; Zhang P; Wang Y; Jin B; Zhou J; Zhang J; Pan J
Clin Cancer Res; 2018 Aug; 24(15):3741-3754. PubMed ID: 29233905
[No Abstract] [Full Text] [Related]
38. Characterization of Uveal Melanoma Cell Lines and Primary Tumor Samples in 3D Culture.
Aughton K; Shahidipour H; Djirackor L; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2020 Jun; 9(7):39. PubMed ID: 32832244
[TBL] [Abstract][Full Text] [Related]
39. ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells.
Kaochar S; Dong J; Torres M; Rajapakshe K; Nikolos F; Davis CM; Ehli EA; Coarfa C; Mitsiades N; Poulaki V
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):132-143. PubMed ID: 29332125
[TBL] [Abstract][Full Text] [Related]
40. Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy.
Kalirai H; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8458-66. PubMed ID: 21896849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]